Rosuvastatin
NDC 82009-191, Rosuvastatin, tablet, film coated, from Quallent Pharmaceuticals Health LLC.
- Product NDC
- 82009-191
- Status
- Listed
- Labeler
- Quallent Pharmaceuticals Health LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA206465
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/82009-191 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ROSUVASTATIN CALCIUM40 mg/1
Pharmacologic classes
HMG-CoA Reductase Inhibitor [EPC]; Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 82009-191-05 | 82009019105 | 500 TABLET, FILM COATED in 1 BOTTLE (82009-191-05) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0d12ae85-71bd-4818-a82d-fd068530bd87NADAC price for package 82009019105
GET /v1/drugs/nadac/82009019105
Use it
Look up 82009-191 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/82009-191 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 82009-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.